Real-World Head-to-Head Analyses Comparing Different Treatment Options For metastatic Castration-Sensitive Prostate Cancer

This educational activity is brought to you by Janssen Biotech, Inc., and is not certified for continuing medical education. The consultant has been paid an honorarium by Janssen Biotech, Inc. The speaker is presenting on behalf of Janssen and must present information in compliance with the U.S. Food and Drug Administration (FDA) requirements applicable to Janssen.
The full ERLEADA® (apalutamide) Prescribing Information can be found here.